{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:00:19Z","timestamp":1788368419964,"version":"build-2803163510"},"reference-count":72,"publisher":"American Academy of Pediatrics (AAP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:p>Newborns, especially those born preterm, are at high risk for infection. Preterm birth rates appear to be increasing in most countries, with \u223c15 million infants born preterm globally each year, corresponding to \u223c11% of all deliveries. Importantly, the vulnerability of preterm infants to infection continues beyond the perinatal period, following them throughout childhood and adolescence, highlighting the long-lasting effects of infection on overall health and well-being. Other than access to clean drinking water and proper sewage systems, immunization is the most effective biomedical intervention to reduce early life infection. Nevertheless, a significant proportion of infants discharged on or after 2 months of age from the NICU remains unimmunized or underimmunized at that time. Despite being safe and effective, protective responses to immunization in early life are different from those in older individuals, in part because of the distinct immune system of newborns and young infants. The paradigms of the Bacille Calmette-Gu\u00e9rin, hepatitis B, and polio vaccines, the only immunizations currently routinely administered in the neonatal period, provide evidence that it is feasible to successfully administer vaccines via different routes of delivery; thus, production of sufficient vaccine-induced immunity leads to disease prevention in the newborn. Strategies such as maternal immunization, adjuvantation systems, leveraging trained immunity, and counseling caregivers can be used to enhance vaccine-induced specific and heterologous protection from infection and boost adherence to the recommended immunization schedule.<\/jats:p>","DOI":"10.1542\/neo.21-12-e817","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T14:26:31Z","timestamp":1606832791000},"page":"e817-e827","source":"Crossref","is-referenced-by-count":16,"title":["Vaccination of Term and Preterm Infants"],"prefix":"10.1542","volume":"21","author":[{"given":"Asimenia","family":"Angelidou","sequence":"first","affiliation":[{"name":"Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA"},{"name":"Precision Vaccines Program, Division of Infectious Diseases, Boston Children\u2019s Hospital, Boston, MA"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[{"name":"Precision Vaccines Program, Division of Infectious Diseases, Boston Children\u2019s Hospital, Boston, MA"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA"},{"name":"Broad Institute of MIT & Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"issue":"2","key":"2021121007402715200_B1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.siny.2015.12.007","article-title":"Global burden of prematurity","volume":"21","author":"Harrison","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"2021121007402715200_B2","unstructured":"World Health Organization. Children: reducing mortality fact sheet. Available at: http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/children-reducing-mortality. Accessed September 1, 2020"},{"issue":"90","key":"2021121007402715200_B3","doi-asserted-by":"crossref","first-page":"90ps27","DOI":"10.1126\/scitranslmed.3001880","article-title":"Development of newborn and infant vaccines","volume":"3","author":"Sanchez-Schmitz","year":"2011","journal-title":"Sci Transl Med"},{"issue":"5","key":"2021121007402715200_B4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ypmed.2013.08.012","article-title":"Which newborns missed the hepatitis B birth dose vaccination among U.S. children?","volume":"57","author":"Zhao","year":"2013","journal-title":"Prev Med"},{"issue":"2","key":"2021121007402715200_B5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jinf.2018.09.014","article-title":"Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months","volume":"78","author":"Wilson","year":"2019","journal-title":"J Infect"},{"issue":"3","key":"2021121007402715200_B6","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1093\/jpids\/pix079","article-title":"Immunization completion in infants born at low birth weight","volume":"7","author":"Nestander","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2021121007402715200_B7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","article-title":"Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study","volume":"396","author":"de Figueiredo","year":"2020","journal-title":"Lancet"},{"key":"2021121007402715200_B8","doi-asserted-by":"crossref","first-page":"m2392","DOI":"10.1136\/bmj.m2392","article-title":"Routine vaccination during covid-19 pandemic response","volume":"369","author":"Saxena","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"2021121007402715200_B9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.immuni.2017.03.009","article-title":"Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny","volume":"46","author":"Kollmann","year":"2017","journal-title":"Immunity"},{"issue":"8","key":"2021121007402715200_B10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(16)00150-X","article-title":"Association of gestational age and growth measures at birth with infection-related admissions to hospital throughout childhood: a population-based, data-linkage study from Western Australia","volume":"16","author":"Miller","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2021121007402715200_B11","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2016.12.985","article-title":"Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses","volume":"140","author":"Dowling","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2021121007402715200_B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00457","article-title":"Soluble mediators regulating immunity in early life","author":"Pettengill","year":"2014","journal-title":"Front Immunol"},{"issue":"5","key":"2021121007402715200_B13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nri2075","article-title":"Innate immunity of the newborn: basic mechanisms and clinical correlates","volume":"7","author":"Levy","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2021121007402715200_B14","article-title":"Vaccine immunology","volume-title":"Plotkin\u2019s Vaccines","author":"Siegrist","year":"2017","edition":"7th ed"},{"issue":"3","key":"2021121007402715200_B15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2021121007402715200_B16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2012.10.014","article-title":"Innate immune function by toll-like receptors: distinct responses in newborns and the elderly","volume":"37","author":"Kollmann","year":"2012","journal-title":"Immunity"},{"key":"2021121007402715200_B17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"key":"2021121007402715200_B18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2018.00029","article-title":"Adjuvant effect of Bacille Calmette-Gu\u00e9rin on hepatitis B vaccine immunogenicity in the preterm and term newborn","volume":"9","author":"Scheid","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"2021121007402715200_B19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1473-3099(19)30414-1","article-title":"Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines","volume":"19","author":"Okomo","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"10142","key":"2021121007402715200_B20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(18)31127-9","article-title":"Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study","volume":"392","author":"Saha","year":"2018","journal-title":"Lancet"},{"key":"2021121007402715200_B21","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"40","year":"1991","journal-title":"MMWR Recomm Rep"},{"key":"2021121007402715200_B22","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"2021121007402715200_B23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.15585\/mmwr.mm6605e1","article-title":"Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2017","volume":"66","author":"Robinson","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8359","key":"2021121007402715200_B24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine","volume":"2","author":"Beasley","year":"1983","journal-title":"Lancet"},{"issue":"8383","key":"2021121007402715200_B25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(84)92388-2","article-title":"Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study","volume":"1","author":"Wong","year":"1984","journal-title":"Lancet"},{"issue":"12","key":"2021121007402715200_B26","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.1985.03350360066020","article-title":"Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization","volume":"253","author":"Stevens","year":"1985","journal-title":"JAMA"},{"issue":"1","key":"2021121007402715200_B27","first-page":"e67","article-title":"Hepatitis B postexposure prophylaxis in preterm and low-birth-weight infants","volume":"5","author":"Waitz","year":"2015","journal-title":"AJP Rep"},{"issue":"21","key":"2021121007402715200_B28","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2012.12.012","article-title":"Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review","volume":"31","author":"Schillie","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"2021121007402715200_B29","doi-asserted-by":"crossref","first-page":"F206","DOI":"10.1136\/fn.79.3.F206","article-title":"Immunogenicity of hepatitis B vaccine in preterm infants","volume":"79","author":"Blondheim","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"2021121007402715200_B30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.vaccine.2016.11.017","article-title":"Polio vaccines: WHO position paper, March 2016\u2014recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"2021121007402715200_B31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame","volume":"3","author":"Est\u00edvariz","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"7","key":"2021121007402715200_B32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2021121007402715200_B33","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","article-title":"The new polio eradication end game: rationale and supporting evidence","volume":"210","author":"Sutter","year":"2014","journal-title":"J Infect Dis"},{"issue":"8","key":"2021121007402715200_B34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG: implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"issue":"24","key":"2021121007402715200_B35","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2018.03.009","article-title":"BCG vaccine: WHO position paper, February 2018: Recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"key":"2021121007402715200_B36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"issue":"12","key":"2021121007402715200_B37","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1080\/21645515.2015.1074361","article-title":"Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants","volume":"11","author":"Saroha","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"2021121007402715200_B38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies","volume":"133","author":"Marciano","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2021121007402715200_B39","first-page":"107","article-title":"BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv Tuberc Res"},{"issue":"5","key":"2021121007402715200_B40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2021121007402715200_B41","first-page":"170","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, October 2009\u2014conclusions and recommendations","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Biologicals"},{"issue":"5","key":"2021121007402715200_B42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/cid\/cix369","article-title":"Effectiveness of rotavirus vaccination: A systematic review of the first decade of global postlicensure data, 2006-2016","volume":"65","author":"Jonesteller","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021121007402715200_B43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40272-018-0283-3","article-title":"Rotavirus vaccines: effectiveness, safety, and future directions","volume":"20","author":"Burnett","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"4","key":"2021121007402715200_B44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/jix590","article-title":"Rotavirus vaccination can be performed without viral dissemination in the neonatal intensive care unit","volume":"217","author":"Hiramatsu","year":"2018","journal-title":"J Infect Dis"},{"issue":"39","key":"2021121007402715200_B45","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1016\/j.vaccine.2015.08.015","article-title":"Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units","volume":"33","author":"Thrall","year":"2015","journal-title":"Vaccine"},{"issue":"10","key":"2021121007402715200_B46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1473-3099(08)70231-7","article-title":"Rotavirus vaccines: viral shedding and risk of transmission","volume":"8","author":"Anderson","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"2021121007402715200_B47","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/INF.0000000000002322","article-title":"Dilemmas with rotavirus vaccine: the neonate and immunocompromised","volume":"38","author":"Chiu","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"2021121007402715200_B48","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1080\/21645515.2015.1074358","article-title":"Immunization of preterm infants","volume":"11","author":"Gagneur","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"23-24","key":"2021121007402715200_B49","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1016\/S0264-410X(02)00230-X","article-title":"Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants","volume":"20","author":"Esposito","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"2021121007402715200_B50","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00281-017-0654-9","article-title":"Vaccine responses in newborns","volume":"39","author":"Saso","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"1","key":"2021121007402715200_B51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/infdis\/170.1.76","article-title":"Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants","volume":"170","author":"Greenberg","year":"1994","journal-title":"J Infect Dis"},{"issue":"9","key":"2021121007402715200_B52","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","article-title":"The value of childhood combination vaccines: From beliefs to evidence","volume":"11","author":"Maman","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"38","key":"2021121007402715200_B53","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1016\/j.vaccine.2017.07.115","article-title":"Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants","volume":"35","author":"D\u2019Angio","year":"2017","journal-title":"Vaccine"},{"issue":"9","key":"2021121007402715200_B54","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4161\/hv.29669","article-title":"Infants and the seasonal influenza vaccine: a global perspective on safety, effectiveness, and alternate forms of protection","volume":"10","author":"Moriarty","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"2021121007402715200_B55","first-page":"67","article-title":"Immunization in preterm and low birth weight infants","volume-title":"Red Book: 2018 Report of the Committee on Infectious Diseases","author":"AAP Committee on Infectious Diseases","year":"2018","edition":"31st ed"},{"issue":"5","key":"2021121007402715200_B56","doi-asserted-by":"crossref","first-page":"e1085","DOI":"10.1542\/peds.2007-2059","article-title":"Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study","volume":"121","author":"Carbone","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"2021121007402715200_B57","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1542\/peds.2005-2957","article-title":"Revalidation of the score for neonatal acute physiology in the Vermont Oxford Network","volume":"119","author":"Zupancic","year":"2007","journal-title":"Pediatrics"},{"issue":"1 pt 1","key":"2021121007402715200_B58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1542\/peds.112.1.193","article-title":"Immunization of preterm and low birth weight infants","volume":"112","author":"Saari","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"2021121007402715200_B59","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpeds.2004.04.006","article-title":"Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events","volume":"145","author":"Pfister","year":"2004","journal-title":"J Pediatr"},{"issue":"2","key":"2021121007402715200_B60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"issue":"11","key":"2021121007402715200_B61","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2021121007402715200_B62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"issue":"6","key":"2021121007402715200_B63","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2021121007402715200_B64","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fmicb.2020.00332","article-title":"BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny","volume":"11","author":"Angelidou","year":"2020","journal-title":"Front Microbiol"},{"issue":"30","key":"2021121007402715200_B65","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Nat Acad Soc U S A"},{"issue":"1","key":"2021121007402715200_B66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOP.0000000000000868","article-title":"Toward precision adjuvants: optimizing science and safety","volume":"32","author":"Nanishi","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"2021121007402715200_B67","first-page":"9","article-title":"The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems","volume":"1","author":"Soni","year":"2020","journal-title":"Pediatr Res"},{"issue":"4","key":"2021121007402715200_B68","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41590-018-0068-4","article-title":"Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses","volume":"19","author":"Ugolini","year":"2018","journal-title":"Nat Immunol"},{"issue":"6","key":"2021121007402715200_B69","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.1542\/peds.2014-3925","article-title":"Strategies to decrease pertussis transmission to infants","volume":"135","author":"Forsyth","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"2021121007402715200_B70","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41467-019-08794-x","article-title":"Dynamic molecular changes during the first week of human life follow a robust developmental trajectory","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"key":"2021121007402715200_B71","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.3389\/fimmu.2018.02634","article-title":"Microphysiologic Human Tissue Constructs Reproduce Autologous Age-Specific BCG and HBV Primary Immunization in vitro","volume":"9","author":"Sanchez-Schmitz","year":"2018","journal-title":"Front Immunol"},{"key":"2021121007402715200_B72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.590373","article-title":"Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference","author":"Soni","year":"2020","journal-title":"Front Immunol"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/21\/12\/e817\/822796\/neoreviews_072020cmerev00111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/21\/12\/e817\/822796\/neoreviews_072020cmerev00111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T19:07:38Z","timestamp":1669921658000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/21\/12\/e817\/92247\/Vaccination-of-Term-and-Preterm-Infants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":72,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,1]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.21-12-e817","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}